- Home
- NHI vs RXRX Comparison
NHI vs RXRX Comparison
Compare NHI & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHI
- RXRX
- Stock Information
- Founded
- NHI 1991
- RXRX 2013
- Country
- NHI United States
- RXRX United States
- Employees
- NHI N/A
- RXRX N/A
- Industry
- NHI Real Estate Investment Trusts
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- NHI Real Estate
- RXRX Health Care
- Exchange
- NHI Nasdaq
- RXRX Nasdaq
- Market Cap
- NHI 3.0B
- RXRX 2.6B
- IPO Year
- NHI 1991
- RXRX 2021
- Fundamental
- Price
- NHI $68.99
- RXRX $9.28
- Analyst Decision
- NHI Buy
- RXRX Buy
- Analyst Count
- NHI 7
- RXRX 4
- Target Price
- NHI $73.57
- RXRX $8.75
- AVG Volume (30 Days)
- NHI 177.4K
- RXRX 32.4M
- Earning Date
- NHI 02-25-2025
- RXRX 02-28-2025
- Dividend Yield
- NHI 5.22%
- RXRX N/A
- EPS Growth
- NHI 19.94
- RXRX N/A
- EPS
- NHI 2.91
- RXRX N/A
- Revenue
- NHI $329,848,000.00
- RXRX $65,184,000.00
- Revenue This Year
- NHI N/A
- RXRX $61.89
- Revenue Next Year
- NHI $14.12
- RXRX $30.83
- P/E Ratio
- NHI $23.70
- RXRX N/A
- Revenue Growth
- NHI 6.05
- RXRX 37.64
- 52 Week Low
- NHI $56.70
- RXRX $5.60
- 52 Week High
- NHI $86.13
- RXRX $15.74
- Technical
- Relative Strength Index (RSI)
- NHI 51.70
- RXRX 58.05
- Support Level
- NHI $65.22
- RXRX $7.33
- Resistance Level
- NHI $70.38
- RXRX $12.36
- Average True Range (ATR)
- NHI 1.49
- RXRX 1.01
- MACD
- NHI 0.31
- RXRX 0.24
- Stochastic Oscillator
- NHI 68.83
- RXRX 43.69
About NHI National Health Investors Inc.
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments i.e. Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived from rental income, mortgage and other notes receivable interest income, and resident fees and services.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.